HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elliott Richelson Selected Research

neurotensin 69L

6/2012NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain.
10/2011The role of NTS2 in the development of tolerance to NT69L in mouse models for hypothermia and thermal analgesia.
1/2011Increased ethanol consumption and preference in mice lacking neurotensin receptor type 2.
2/2010Chronic NT69L potently prevents drug-induced disruption of prepulse inhibition without causing tolerance.
1/2010The novel neurotensin analog NT69L blocks phencyclidine (PCP)-induced increases in locomotor activity and PCP-induced increases in monoamine and amino acids levels in the medial prefrontal cortex.
7/2009Evidence for a role of NTS2 receptors in the modulation of tonic pain sensitivity.
9/2008Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain.
10/2003Current topics: brain penetrating neurotensin analog.
10/2003Selective tolerance to the hypothermic and anticataleptic effects of a neurotensin analog that crosses the blood-brain barrier.
1/2003Blockade of nicotine-induced locomotor sensitization by a novel neurotensin analog in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elliott Richelson Research Topics

Disease

10Schizophrenia (Dementia Praecox)
01/2013 - 10/2003
7Pain (Aches)
08/2013 - 05/2008
5Parkinson Disease (Parkinson's Disease)
01/2013 - 01/2002
5Hypothermia
10/2011 - 10/2003
5Tobacco Use Disorder (Nicotine Dependence)
09/2008 - 01/2003
3Alzheimer Disease (Alzheimer's Disease)
01/2004 - 08/2002
1Treatment-Resistant Depressive Disorder
07/2022
1Ischemia
10/2014
1Hemorrhagic Stroke
10/2014
1Mental Disorders (Mental Disorder)
06/2014
1Cocaine-Related Disorders (Cocaine Addiction)
03/2014
1Sleep Initiation and Maintenance Disorders (Insomnia)
08/2013
1Neoplasms (Cancer)
01/2013
1Inflammation (Inflammations)
01/2013
1Substance-Related Disorders (Drug Abuse)
01/2013
1Feeding and Eating Disorders (Eating Disorder)
01/2013
1Visceral Pain
06/2012
1Ataxia (Dyssynergia)
01/2011
1Brain Diseases (Brain Disorder)
01/2010
1Hypotension (Low Blood Pressure)
01/2010
1Dyspepsia (Indigestion)
08/2008
1Weight Gain
01/2007
1Hot Flashes
06/2006
1Acute Liver Failure (Fulminant Hepatic Failure)
06/2006
1Brain Injuries (Brain Injury)
06/2006
1Brain Edema (Cerebral Edema)
06/2006
1Edema (Dropsy)
06/2006
1Central Nervous System Diseases (CNS Diseases)
04/2005
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2004
1Catalepsy
10/2003

Drug/Important Bio-Agent (IBA)

15NeurotensinIBA
06/2014 - 01/2002
10neurotensin 69LIBA
06/2012 - 01/2003
5Neurotransmitter Agents (Neurotransmitter)IBA
06/2014 - 01/2002
4Therapeutic UsesIBA
03/2014 - 04/2005
4Neurotensin Receptors (Neurotensin Receptor)IBA
11/2010 - 03/2005
3Analgesics (Analgesic Drugs)IBA
06/2012 - 05/2008
3Formaldehyde (Formol)FDA Link
09/2011 - 05/2008
3Proteins (Proteins, Gene)FDA Link
11/2010 - 01/2003
3Antipsychotic Agents (Antipsychotics)IBA
01/2010 - 01/2007
3Amyloid beta-PeptidesIBA
01/2004 - 08/2002
2NeuropeptidesIBA
06/2014 - 01/2007
2Cocaine (Cocaine HCl)IBA
03/2014 - 10/2003
2Pharmaceutical PreparationsIBA
03/2014 - 08/2013
2NicotineFDA Link
03/2014 - 01/2003
2Amphetamine (Amfetamine)FDA LinkGeneric
11/2010 - 06/2010
2ApomorphineFDA Link
01/2010 - 10/2003
2Dextroamphetamine (Dexedrine)FDA LinkGeneric
01/2010 - 10/2003
2Peptide Hydrolases (Proteases)FDA Link
10/2006 - 04/2005
2Amyloid (Amyloid Fibrils)IBA
01/2004 - 01/2003
1Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA
07/2022
1Phenelzine (Nardil)FDA Link
07/2022
1Tranylcypromine (Parnate)FDA LinkGeneric
07/2022
1IsocarboxazidFDA Link
07/2022
1Hemin (Panhematin)FDA Link
10/2014
1Butyric Acid (Butanoic Acid)IBA
08/2013
1Histamine (Histamine Dihydrochloride)FDA Link
08/2013
1levocabastine (Bilina)FDA Link
06/2012
1Morphine (MS Contin)FDA LinkGeneric
09/2011
1Ethanol (Ethyl Alcohol)IBA
01/2011
1Hypnotics and Sedatives (Sedatives)IBA
01/2011
1Phencyclidine (Angel Dust)IBA
11/2010
1Amino AcidsFDA Link
06/2010
1Glutamic Acid (Glutamate)FDA Link
01/2010
1Dopamine (Intropin)FDA LinkGeneric
01/2010
1Acetic Acid (Vinegar)FDA LinkGeneric
01/2010
1Naloxone (Narcan)FDA LinkGeneric
07/2009
1Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA
08/2008
1PD149163IBA
05/2008
1SR 48692IBA
05/2008
1Capsules (Microcapsules)IBA
06/2006
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
06/2006
1N- (2(R)- 2- (hydroxamidocarbonylmethyl)- 4- methylpentanoyl)- L- tryptophan methylamideIBA
06/2006
1Matrix Metalloproteinases (MMPs)IBA
06/2006
1Monoclonal AntibodiesIBA
06/2006
1Peptides (Polypeptides)IBA
04/2005
1amyloid beta-protein (1-42)IBA
01/2004
1Hydrocortisone (Cortisol)FDA LinkGeneric
10/2003
1Haloperidol (Haldol)FDA LinkGeneric
10/2003
1Blood Glucose (Blood Sugar)IBA
10/2003

Therapy/Procedure

3Analgesia
06/2012 - 07/2009
1Therapeutics
09/2011
1Hypnosis (Mesmerism)
01/2011
1Drug Therapy (Chemotherapy)
01/2010
1Spinal Injections
07/2009